JOINN Laboratories (China) Co., Ltd. has recently collaborated with Staitech Bio-technology (Beijing) Co., Ltd. to jointly develop a "Digital Pathology Assisted Analysis System". The system has been widely recognized in practical applications, marking a crucial step for the company in the processes of automation and intelligence, as well as heralding the beginning of a new chapter in AI-driven drug development.

Both JOINN Lab and Staitech Bio-tech are high-tech companies based in Beijing E-Town.

The Digital Pathology Assisted Analysis System combines JOINN's rich experience and vast background data in non-clinical pathology with Staitech's advantageous algorithms in AI. This collaboration has enabled applications such as AI-assisted diagnosis in multiple organ categories of experimental animal species, intelligent quality control of digital pathology slides, and autonomous training of AI models.

The application of AI-assisted diagnosis makes pathology diagnosis faster and more accurate. After analyzing data with AI, the efficiency in some processes can be improved by 50 to 100 times, with accuracy, consistency and efficiency far surpassing manual methods.

Going forward, JOINN will continue to deepen the integration with AI technology, constantly exploring more possibilities combined with drug development.